The Complete Guide to Biomarker Testing

Most of the conditions that end lives give no symptoms for a decade — and show up in cheap blood work for years before they do. A sensible testing schedule is one of the highest-value habits in all of preventive medicine. The catch: the testing industry has discovered that anxiety sells. Here's what to measure, how often, and what to politely skip.

The Core Panel, Item by Item

Why these particular tests, in one sentence each. Blood pressure: the single most consequential vital sign, treatable at every stage. ApoB: the particle count that drives atherosclerosis — the cardiovascular number with the cleanest causal evidence. Fasting glucose and HbA1c: the metabolic pair that catches prediabetes in its silent, fully reversible decade. Fasting insulin: the early-warning hormone that rises years before glucose does. Waist and waist-to-height: the free, monthly, home-owned proxy for the fat depot that matters. Lp(a): the genetic flag you read once and factor forever. Together they cover the four horsemen — cardiovascular, metabolic, hepatic, and renal risk — for the price of a dinner, and they're the tests every other page in this pillar exists to explain.

The Core Panel: What and How Often

The complete panel above costs roughly the price of a dinner out, requires one blood draw, and covers the conditions that cause the majority of premature death. Everything in it is guideline-grade screening. Everything below gets murkier.

Age-Adjusted Additions

• 40s–50s: Add a baseline colonoscopy (or validated stool testing) from ~45; add mammography / prostate discussion per your clinician's screening schedule; consider a coronary calcium (CAC) scan if risk is intermediate — it's the one imaging test with genuine decision value.
• 50s–60s: Bone density (DXA) for women at menopause and men with risk factors; vision and hearing checks (sensory loss is a fall risk and a cognitive-health risk).
• Every decade: the exercise pillar's functional tests — grip, single-leg balance, sit-to-stand, gait speed. They're free, take minutes, and predict more than most blood work.

What to Politely Skip

Before the table: the skip list isn't a prohibition — it's an honesty requirement. Each skipped test below has a defensible niche use (a whole-body MRI after a concerning finding, a hormone panel for a specific symptom, a microbiome sample in a trial). What they don't have is a defensible routine use, and routine is what's being sold. The wellness industry's business model is converting health anxiety into subscriptions; the sober countermove is remembering that a test only earns its place by changing a decision.

The pattern behind the skip list: a test earns its place only if the result changes a decision. If the answer would be "observe" regardless of the number, the test is data collection, not medicine — and data collection has its own costs.

The Coronary Calcium Scan: The Exception That Proves the Rule

One imaging test belongs in a sensible program, and it's the exception to this topic's skepticism: the coronary artery calcium (CAC) scan — a low-radiation CT that measures calcified plaque in your heart's arteries. What makes it different from the wellness-scan industry: it changes decisions. A CAC score of zero in a 55-year-old with borderline lipids is a strong argument against starting a statin; a high score in the same person is a strong argument for aggressive treatment — the same blood numbers, opposite actions, decided by a scan that costs roughly $100–200 and takes minutes. The honest caveats: it's most useful for people at intermediate risk (where the decision is genuinely uncertain), it detects calcified plaque but not soft plaque, and it's not for everyone. But if one test in this topic deserves the word "underused," it's this one.

The Testing Philosophy, In Three Rules

Everything in this guide follows three rules. First: test things whose results change decisions. Blood pressure changes treatment; a "biological age" of 52 instead of 54 changes nothing actionable. Second: prefer trends over snapshots. The human body is a noisy system; one value is weather, three annual values are climate. Third: the cheapest useful test beats the most impressive useless one. A tape measure and a blood-pressure cuff, used monthly with discipline, outperform a $3,000 imaging package used once. Testing is a tool for action, not a substitute for it — the fanciest panel in the world doesn't walk, lift, or sleep for you.

A Year in Testing: The Calendar

Total annual cost of the full schedule: a home cuff once, a tape measure, and one blood draw. The schedule is deliberately front-loaded toward things you own — the at-home measurements run monthly because they're free and sensitive; the lab runs annually because its markers move slowly and the slope is what matters.

When Something Comes Back Abnormal

The most important skill in testing isn't ordering — it's responding. The algorithm that prevents both panic and neglect: confirm first (one abnormal value gets repeated, not celebrated or mourned — measurement error and biology both fluctuate), contextualize (a borderline result in a low-risk person is a watch; the same number with a family history is a conversation), start with the pillars (most first-line responses are the sleep, exercise, and nutrition levers this entire site documents), and escalate by risk, not by anxiety — a persistently abnormal result in a high-risk person belongs with a physician, where the full toolkit lives. The goal was never a perfect panel; it's a panel that gets acted on while action still works.

Testing Questions, Answered Briefly

• Where do I order the core panel? Your primary-care clinician can order all of it — and insurance typically covers the guideline-based lines. Direct-to-consumer labs are a fallback, not the default.
• What if my doctor resists ApoB or insulin? The conversation usually goes well when framed as "I'd like to add these two cheap lines to my annual panel." Guideline support for both has grown substantially.
• How young should testing start? The full panel is reasonable from the 30s for most people; earlier with family history, obesity, or other risk factors. Blood pressure and waist cost nothing and start anytime.

Go Deeper: Subtopics

• 🔎 The tiered panel — what to test annually vs once vs only with symptoms: a pragmatic hierarchy. Read it →
• 🔎 Reference ranges vs optimal ranges — why "normal" lab ranges aren't longevity targets, and the honest caveats. Read it →
• 🔎 Testing cadence & cost — what's worth paying for out-of-pocket and what isn't. Read it →
• 🔎 Interpreting trends, not snapshots — biological noise, repeat-testing logic, and regression to the mean. Read it →
• 🔎 Biomarkers that mislead — the overrated tests (and the underrated ones) in the longevity market (links Quarterly Audit). Read it →

Related Topics